Stay updated on Pembrolizumab with Targeted Therapy Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.

Latest updates to the Pembrolizumab with Targeted Therapy Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, signaling a small maintenance update. This update does not change the study details or visible content.SummaryDifference0.0%

- Check19 days agoChange DetectedAn updated informed consent form (Revision: v3.6.2) is now available as a PDF on the study page, replacing the older version. This update ensures current consent materials are accessible to participants.SummaryDifference0.5%

- Check33 days agoChange DetectedNew navigation and help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was updated. The page now displays 'No longer looking for participants' to reflect recruitment status, and the revision tag changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check41 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5. This reflects a minor internal update to the page rather than a change to study content.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a new release or patch was applied. This appears to be an internal versioning update rather than a user-visible content change.SummaryDifference0.0%

- Check84 days agoChange DetectedA revision/version label on the page footer was updated from v3.5.2 to v3.5.3, reflecting a technical software release rather than a change to the represented clinical trial information.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab with Targeted Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Targeted Therapy Clinical Trial page.